For the latest COVID-19 campus news and resources, visit

Search Close Search
Page Menu

Experimental Therapeutics

The Experimental Therapeutics (ET) Program brings together translational and clinical researchers to discover and validate novel cancer targets, and to develop and test new therapeutics, treatment strategies and biomarkers for cancer. Research in the ET Program aims to:

  • Guide drug discovery efforts by identifying factors and regulatory pathways that can be targeted to selectively eradicate cancer cells
  • Develop novel cancer therapeutic agents (e.g., small molecule inhibitors and therapeutic RNAs) and repurpose approved drugs for cancer indications
  • Develop delivery approaches and systems for cancer therapeutics
  • Conduct clinical trials to evaluate new chemotherapy treatment options, improve surgical procedures for quality and outcomes improvement, and identify novel markers for diagnostic and prognostic predictors of outcome


Getting Results…